Silo Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Silo Pharma, Inc. (SILO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents3.913.5211.379.841.13
Short-Term Investments3.174.140.000.420.00
Cash & Short-Term Investments7.087.6711.3710.261.13
Accounts Receivable0.000.000.070.000.02
Inventory0.000.000.000.000.00
Other Current Assets0.030.020.120.150.13
Total Current Assets7.117.6811.5710.401.43
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Intangible Assets0.240.000.000.000.00
Other Non-Current Assets0.060.060.070.030.00
Total Non-Current Assets0.300.060.070.090.00
Total Assets7.417.7511.6410.491.43
Current Liabilities
Accounts Payable1.580.700.220.420.13
Short-Term Debt0.000.000.000.000.01
Current Portion of Long-Term Debt0.000.000.000.000.01
Accrued Liabilities0.000.000.140.000.00
Deferred Revenue0.070.070.070.070.00
Other Current Liabilities0.000.000.000.000.00
Total Current Liabilities1.660.780.440.490.14
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.720.790.870.940.00
Total Liabilities2.381.571.301.430.15
Stockholders' Equity
Common Stock0.000.000.000.000.01
Retained Earnings-15.26-10.87-7.17-3.26-5.76
Accumulated Other Comprehensive Income0.00-0.010.000.000.00
Treasury Stock0.000.470.000.000.00
Additional Paid-in Capital20.3017.5317.5112.320.00
Shares Outstanding4.482.913.161.970.00
Total Stockholders' Equity5.036.1810.349.061.28
Total Liabilities & Equity7.417.7511.6410.490.00